L-Carnitine for Weight Management

Strong evidence 15 studies

Research suggests that L-carnitine supplementation may produce modest benefits for weight management, particularly in individuals who are overweight or obese. A 2020 meta-analysis pooling data from 43 randomized controlled trials found statistically significant but small reductions in body weight, BMI, and fat mass, while a 2026 systematic review and network meta-analysis found L-carnitine showed the most consistent benefits across weight and metabolic outcomes compared to several other nutraceuticals, and a 2023 randomized controlled trial suggested that combining L-carnitine with a synbiotic may amplify these effects beyond what L-carnitine alone produces. Studies indicate that effects appear more pronounced when supplementation is paired with other lifestyle changes such as diet or exercise, and that simply increasing the dose does not reliably increase results, pointing to a more complex dose-response relationship. That said, a narrative review examining the broader weight-management supplement landscape characterized the overall evidence base as not yet consistent or robust enough to draw firm conclusions, and several studies in the linked set address unrelated topics such as rare metabolic disorders, computational modeling, and animal physiology, which do not contribute meaningfully to the human weight-loss question and underscore the importance of evaluating evidence specific to the population and outcome of interest.

Related studies

Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.

Title Type Year Direction Match
Beneficial effects of l-carnitine supplementation for weight management in ov... Meta-analysis 2020 Supports 100
Ameliorating effects of L-carnitine and synbiotic co-supplementation on anthr... RCT 2023 Supports 95
Nutraceuticals for the management of weight and inflammation-related complica... Systematic review 2026 Supports 90
Consumer Perceptions Influence Supplement Choice: A Narrative Review of Clini... Review 2026 Mixed 85
A multiomic network approach uncovers disease modifying mechanisms of inborn ... Other 2025 Neutral 85
Dynamic whole-body models for infant metabolism Other 2024 Neutral 80
Review: Evidence-based Clinical Research of Anti-obesity Supplements in Japan. Other 2013 Mixed 80
Biological landscape of acute illness in children in sub-Saharan Africa and S... Other 2025 Neutral 75
Cats in Positive Energy Balance Have Lower Rates of Adipose Gain When Fed Die... Other 2016 Supports 75
Targeting immunometabolic pathways with AZD1656 alleviates inflammation and m... Other 2025 Neutral 70
Mechanistic basis for protection against fatty liver disease by <i>CIDEB</i> ... Other 2025 Neutral 65
Personalised metabolic whole-body models for newborns and infants predict gro... Other 2023 Neutral 60
Upregulation of steroidogenesis is associated with coma in human cerebral mal... Other 2023 Neutral 55
Mitochondrial dysfunction and mitophagy blockade contribute to renal osteodys... Other 2023 Neutral 50
Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory protei... Other 2023 Neutral 45

← Back to L-Carnitine

Medical Disclaimer: Noyemi provides information from published research for educational purposes only. This content is not medical advice and does not replace consultation with a qualified healthcare provider. Always consult your doctor before starting, stopping, or changing any supplement regimen, especially if you take medications or have existing health conditions.